Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
Northern Trust | NTRS | 9. oct 2024 | 91.53 | +0.52 |
Northern Trust E Pref | NTRSO | 9. oct 2024 | 23.08 | -0.52 |
Northfield Bancorp | NFBK | 9. oct 2024 | 11.21 | +1.17 |
Northrim BanCorp | NRIM | 9. oct 2024 | 67.20 | -0.03 |
Northrop Grumman | NOC | 9. oct 2024 | 532.23 | -0.08 |
NorthView Acquisition | NVAC | 9. oct 2024 | 11.70 | 0.00 |
Northwest Bancshares | NWBI | 9. oct 2024 | 12.95 | +0.31 |
Northwest Natural Holdings | NWN | 9. oct 2024 | 38.84 | 0.00 |
Northwest Pipe | NWPX | 9. oct 2024 | 43.47 | +0.95 |
NorthWestern Energy | NWE | 9. oct 2024 | 54.56 | -0.31 |
Norwegian Cruise Line | NCLH | 9. oct 2024 | 23.07 | +10.91 |
Norwood Financial | NWFL | 9. oct 2024 | 27.94 | +1.20 |
Notable Labs | NTBL | 9. oct 2024 | 0.39 | -1.31 |
Nouveau Monde Graphite | NMG | 9. oct 2024 | 1.49 | 0.00 |
NOV | NOV | 9. oct 2024 | 16.07 | 0.00 |
Nova | NVMI | 9. oct 2024 | 210.72 | +0.94 |
Nova Lifestyle | NVFY | 9. oct 2024 | 1.34 | +1.52 |
Nova Minerals | NVA | 9. oct 2024 | 6.59 | 0.00 |
Nova Vision Acquisition | NOVV | 9. oct 2024 | 37.00 | 0.00 |
Novabay Pharmaceuticals | NBY | 9. oct 2024 | 0.68 | 0.00 |
Novagold Resources | NG | 9. oct 2024 | 3.37 | 0.00 |
Novanta | NOVT | 9. oct 2024 | 174.98 | +0.24 |
Novartis ADR | NVS | 9. oct 2024 | 115.64 | +1.64 |
Novavax | NVAX | 9. oct 2024 | 12.68 | -2.76 |
Novo Integrated Sciences | NVOS | 9. oct 2024 | 0.26 | +4.82 |
Novo Nordisk ADR | NVO | 9. oct 2024 | 117.00 | -0.17 |
NovoCure | NVCR | 9. oct 2024 | 14.66 | 0.00 |
Novonix ADR | NVX | 9. oct 2024 | 2.28 | +16.33 |
NRG Energy | NRG | 9. oct 2024 | 93.56 | 0.00 |
NRx Pharmaceuticals | NRXP | 9. oct 2024 | 1.47 | -0.68 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.